At first glance, Alphabet's third-quarter earnings looked impressive. Total revenue increased 25% year over year to $127.6 ...

Furthermore, the entire AI stock trade has been reeling in recent weeks. Practically every stock in that industry is a ...

Merck’s new drugs are growing fast enough to cover generic losses, but part of this quarter’s sales gain won’t last. Here’s ...

Net charge-offs stayed below 10 basis points for nine of the last ten quarters, signaling durable credit discipline through ...

Partner renewals are shifting toward profit-sharing models, aligning incentives with portfolio performance.

AI-driven title search automation and commercial expansion are Stewart's levers to sustain margins through a prolonged ...

Platform upgrades and AI gains come with near-term friction, but management is betting on scale to justify the short-term ...

FTAI also lacks free cash flow with which to fund the buybacks. Although the company didn't include a cash flow statement ...

Management's willingness to walk away from deals when spreads don't justify returns signals a shift toward quality over ...

Caterpillar’s sales jumped 17% and margins widened, yet the stock dropped about 8%. Here’s what’s behind the gap, from a ...

Apple and Nvidia are the only two companies with market caps above $5 trillion today. Apple is ready to zoom past Nvidia.

It's not that rare to see stocks in the volatile biotech industry that quadruple (or more) in value over a relatively short ...